
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
Click the title above for a link to open the Pharmaceutical Executive February 2025 issue in an interactive PDF format.
almost 2 years ago
At First Glancealmost 2 years ago
2025 Pipeline Report: The Edge of Greatness?almost 2 years ago
Inclusive Marketing: Engaging with Purposealmost 2 years ago
Proactive Engagement: How AI-Driven Alerts are Transforming HCP Outreachalmost 2 years ago
The Shifting Pharmacy Landscape in 2025almost 2 years ago
Navigating the EU’s Joint Clinical Assessmentalmost 2 years ago
Biopharma Business Check: Financing Review and Outlookalmost 2 years ago
Statistically and Clinically Significant Paths to Value Propositionalmost 2 years ago
AI: Hungry for Power





